In a major advancement to drive enhanced early cancer detection for historically underserved populations, the Multicancer Early Detection (MCED) Consortium, comprised of U.S. and U.K. organizations focused on, among other health equity initiatives, improving MCED technologies, announced today the release of two research papers intended to help close the gap in disparities in cancer care across populations.
The white papers, entitled Patient Barriers to Care: A Health Equity Landscape Analysis for Emerging Multicancer Early Detection Tests and Building Health Equity through Research Study Design for Multicancer Early Detection Tests: Key Considerations, were developed by the Consortium’s Health Equity Workgroup.
The documents analyze the advantages, drawbacks, and barriers that can be changed to make MCEDs more acceptable and accessible to underrepresented and diverse populations. They provide valuable recommendations to ensure equitable and knowledgeable engagement with these emerging technologies.
These papers are important contributions to better understanding the process of exploring how MCED technologies can help reduce inequalities in cancer detection, treatment and patient outcomes.
